ArticleThe Journal of clinical investigation2015

Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.

Subhamoy Dasgupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.